Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. 1. Effective September 20, 2006, the Company's Chief Financial Officer, Thomas W. Fry, resigned from that position. Mr. Fry will continue to act as a consultant to the Company. 2. Effective September 20, 2006, Tricia Efstathiou, Controller of the Company for in excess of five years, was appointed its Chief Financial Officer. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VASOMEDICAL, INC. /s/ Thomas Glover By: ------------------------------------ Thomas Glover President and Chief Executive Officer Dated: September 25, 2006